Reducing market access risk: how digital technology is strengthening strategies

Developing innovative pharmaceutical products is a lengthy process with no guarantee of success at the end. Manufacturers struggle with coordinating strategy internally and incorporating multiple payer requirements in clinical development programs. In the fourth of her five-part series on digital… Continue Reading

The things you need to know about the digital transformation of primary research

In the rapidly evolving market access landscape, it’s important to quickly identify current payer perspectives to determine future trends. High-quality, rapid primary research can be key to fast-forwarding your strategy. Continue Reading

Payer and HTA submissions: how digital technology is transforming market access processes

In the first of her five-part series on digital transformation in market access, Dr Patti Peeples, CEO of HealthEconomics.com, sits down with Claire Chadwick, HTA Manager at PRMA Consulting. Continue Reading

Sex Reassignment Surgery For Transgenders: Should It Be Covered By Health Insurance?

People who identify themselves as transgender evolved in their belief of a gender-assignment mistake when they are self-aware of stereotypes involving genders, which can occur as early as the age of three years old. This sense of identity can adversely… Continue Reading

Paying for Specialty Pharmaceuticals: The Case of Injectable Oncology Drugs

According to the American Cancer Society, the financial costs of cancer are high for both the person with cancer and for society as a whole. The National Institutes of Health (NIH) estimated the 2009 overall annual costs of cancer in… Continue Reading